More tools:Markets·Screener·Research·Chat

Nature's Sunshine Products Inc. (NATR) Financial Statements

Nature's Sunshine Products Inc.
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S61DP6
XNAS · usd
13.80▼ 0.02 (-0.14%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value—
Trailing P/E
Price / Sales
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt—
Trading Information
Previous Close13.82
Day's Range13.65 – 14.17
52-Week Range12.97 – 28.14
Volume148.1K
Avg Volume209.5K
Share Statistics
Shares Outstanding
Employees806
ExchangeXNAS
Listed1980-08-07
Share count as of July 24, 2026
Loading Income Statement…
Key questions about Nature's Sunshine Products Inc. (NATR)
What is Nature's Sunshine Products Inc.'s Market Cap?
Nature's Sunshine Products Inc.'s Market Cap is $242.8M, based on as-reported figures from SEC (XBRL) filings.
What is Nature's Sunshine Products Inc.'s Trailing P/E?
Nature's Sunshine Products Inc.'s Trailing P/E is 13.4×, based on as-reported figures from SEC (XBRL) filings.
What is Nature's Sunshine Products Inc.'s Price / Sales?
Nature's Sunshine Products Inc.'s Price / Sales is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is Nature's Sunshine Products Inc.'s Revenue (TTM)?
Nature's Sunshine Products Inc.'s Revenue (TTM) is $492.0M, based on as-reported figures from SEC (XBRL) filings.
What is Nature's Sunshine Products Inc.'s Net Income (TTM)?
Nature's Sunshine Products Inc.'s Net Income (TTM) is $18.1M, based on as-reported figures from SEC (XBRL) filings.
What is Nature's Sunshine Products Inc.'s EBITDA?
Nature's Sunshine Products Inc.'s EBITDA is $42.7M, based on as-reported figures from SEC (XBRL) filings.
What is Nature's Sunshine Products Inc.'s Diluted EPS (TTM)?
Nature's Sunshine Products Inc.'s Diluted EPS (TTM) is 1.03, based on as-reported figures from SEC (XBRL) filings.
What is Nature's Sunshine Products Inc.'s EBITDA Margin?
Nature's Sunshine Products Inc.'s EBITDA Margin is 8.7%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net sales
YoY growth+1.9%+8.5%+4.7%+12.0%
Cost of sales
Gross profit
% of revenue73.7%73.2%72.5%73.3%
Operating expenses:
Volume incentives
Selling, general and administrative
Operating income
% of revenue4.7%7.8%4.3%7.0%
Other income (expense):
Interest and other income, net
Interest expense
Foreign exchange gains (losses), net
Other income—
Income before provision for income taxes
Provision for income taxes
Net income
% of revenue3.0%4.2%3.6%4.3%
Net income attributable to noncontrolling interests
Net income attributable to common shareholders
% of revenue3.0%4.2%3.3%4.2%
Basic earnings per share attributable to common shareholders (in dollars per share)
Diluted earnings per share attributable to common shareholders (in dollars per share)